Search Results

Keywords: dronabinol

Tilray adds dronabinol to German product portfolio

Canadian cannabis producer Tilray is offering dronabinol in the German medical cannabis market, according to a notice in the German trade publication Apotheke AdHoc. Tilray’s dronabinol is plant-derived – like most, if not all, of the dronabinol available in Germany. According to the notice, Tilray sources the dronabinol from manufacturer Echo Pharmaceuticals in the Netherlands. […]

Read More

Synthetic cannabinoids linked to increased hospitalizations and deaths in older adults with COPD

A study out of St. Michael’s Hospital in Toronto has found prescription synthetic cannabinoids are linked to a 64-percent increase in death in older patients with chronic obstructive pulmonary disease (COPD). These oral drugs—nabilone and dronabinol—have a chemical structure similar to THC and are often prescribed to treat symptoms associated with COPD, including pain, sleep […]

Read More

German patient wins court case to have cannabis covered by insurance

A German patient won a long legal battle against her statutory health-insurance provider involving medical cannabis reimbursement. The Social Court of Berlin and Brandenburg ruled that the health insurer must cover the cost of dronabinol drops for at least one year. The news is positive for patient access to medical cannabis and companies looking to […]

Read More

Insurance-covered medical cannabis falls for the first time in Germany

Insurance reimbursements for cannabis in Germany dropped for the first time – on a quarterly basis – since the current medical program started in early 2017, according to new data for the quarter ended June 30, 2020. The reason: Prices fell while the number of prescriptions barely grew. This is consistent with Marijuana Business Daily’s […]

Read More

Global Retreat: Canadian cannabis firms pull back global aspirations

Back in the early days of Canada’s regulated adult-use cannabis industry, some of the country’s biggest publicly traded marijuana producers discovered that investors rewarded international ambitions. The domestic recreational marijuana market that launched in October 2018 was exciting, of course, but that opportunity would always be limited by Canada’s relatively small population of around 38 […]

Read More

Insurance-covered reimbursements for medical cannabis sets record in Germany

Insurance reimbursements for medical cannabis in Germany continue to reach fresh quarterly records, according to new data for the January-March period. In the first quarter of 2020, total reimbursement of cannabis and marijuana-related medicines reached 38.9 million euros ($43.7 million), the German National Association of Statutory Health Insurance Funds (GKV-Spitzenverband) reported. That is 6% higher […]

Read More

Competition grows in Germany’s medical cannabis extracts market

Canadian cannabis producer Tilray announced the availability of a new full-spectrum extract for Germany’s medical market, the company’s first product in that market offering a larger CBD concentration than THC. The product has 5 milligrams of THC per millilitre and 20 milligrams of CBD per millilitre. Tilray’s announcement didn’t disclose the size of the bottle. […]

Read More

Uruguay sends another record-breaking shipment of cannabis flower to Europe

Uruguay-based Fotmer Life Sciences exported another large shipment of medical cannabis to Portugal in May – this one totaling almost 1.5 metric tons (3,307 pounds), according to Uruguayan customs documents viewed by Marijuana Business Daily.  The overseas shipment comes about six months after Fotmer sent 1 metric ton of high-THC cannabis flower to Portugal. The […]

Read More